Archive for October, 2011

IBM and Georgia Tech launch “One Million Healthy Children” initiative

IBM and Georgia Tech have launched a new research initiative to integrate the massive amounts of data related to children’s health, extending far beyond laboratory test data to include factors like socio-economic status, food resources, education attainment, and access to transportation and health care services.  With an initial focus on children suffering from diabetes, with asthma and autism to follow, the goal of the initiative is to improve pediatric care.    Other partners in the collaboration are Children’s Healthcare of Atlanta, Emory University, the Georgia Cancer Coalition, and the Georgia Department of Community Health.  Read more here>

October 27, 2011 at 10:28 am Leave a comment

VaxyGen and Georgia State University enter collaboration and licensing agreement

VaxyGen Manufacturing Services, a Georgia Research Alliance VentureLab company, has entered an exclusive license and collaboration agreement with the Georgia State University Research Foundation to provide the company with exclusive rights to a novel patent for producing and purifying proteins in development as biopharmaceutical and vaccine products.  The collaboration agreement is to commercialize the work of the GSU Biological Process Development and Research Laboratory.  In addition to introducing VaxyGen’s president and CEO David Dodd to researchers at GSU, GRA has invested in equipping the Biological Process laboratory.  Read more here>

October 27, 2011 at 10:07 am Leave a comment

GRA Eminent Scholar Rafi Ahmed featured in Khabar Magazine

Khabar Magazine, a publication for and about the Indian-American community, featured a profile of GRA Eminent Scholar Rafi Ahmed (Emory University) in its October issue.  The article follows Ahmed’s path to becoming a global leader in virology and immunology.   Read the article>

October 25, 2011 at 2:07 pm Leave a comment

GRA Eminent Scholar Barbara Boyan to lead new Atlanta Pediatric Device Consortium

The U.S. Food and Drug Administration has awarded the Georgia Institute of Technology, Children’s Healthcare of Atlanta (CHOA), Emory University and Saint Joseph’s Translational Research Institute a two-year, $1.8 million grant to foster the development of medical devices focused on the special needs of children. The award will launch the new Atlanta Pediatric Device Consortium, which will provide assistance with engineering design, prototype development, pre-clinical and clinical studies and commercialization for novel pediatric medical devices.

The consortium will be led by GRA Eminent Scholar Barbara Boyan of Georgia Tech and co-directors Kevin Maher, a cardiologist and researcher with CHOA and Emory University, and Wilbur Lam, a pediatric hematologist/oncologist and bioengineer with appointments at Emory, the Aflac Cancer Center of CHOA and Georgia Tech.  Read more>

October 13, 2011 at 3:38 pm Leave a comment

Emory Vaccine Center joins partnership to advance vaccine R&D worldwide

The Emory Vaccine Center, under the leadership of GRA Eminent Scholar Rafi Ahmed, is partnering with 42 universities and research institutions in 13 countries to accelerate human vaccine development through a new collaborative research program called Advanced Immunization Technologies (ADITEC).

The partnership, led by Novartis, was launched October 1 with 30 million euros in funding over five years from the European Union and 11 million euros in co-funding from collaborating organizations. ADITEC will develop new technologies and a robust platform for innovation in the next generation of human vaccines.   Read more here>

October 11, 2011 at 3:57 pm Leave a comment

Treating the complications of diabetes

GRA Eminent Scholar Xiaodong Cheng and Emory University School of Medicine colleague Young-Sup Yoon have been awarded a $6.1 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases to reprogram cells to treat complications of diabetes.  The cells, taken from the bone marrow or peripheral blood of diabetic patients, will help to fight neurovascular complications of the disease, including peripheral artery disease and diabetic neuropathy.  Also part of the research team are scientists from Georgia Tech, the University of Alabama and the University of California at San Diego.  Read more>

October 10, 2011 at 9:50 am Leave a comment